Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Restricted Stock (Details)

v3.23.1
Stockholders' Equity - Restricted Stock (Details) - Restricted Stock - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Stockholders' Equity    
Non-vested beginning balance 451,266 386,982
Number of Shares, Granted 159,416 122,900
Number of Shares, Forfeited (15,850) (1,566)
Number of Shares, Vested (215,935) (57,050)
Non-vested ending balance 378,897 451,266
Weighted Average Exercise Price, beginning balance $ 33.48 $ 36.09
Weighted Average Grant Date Fair Value, Granted 20.00 28.61
Weighted Average Grant Date Fair Value, Forfeited 30.19 22.43
Weighted Average Grant Date Fair Value, Vested 36.63 41.02
Weighted Average Exercise Price , ending balance $ 26.15 $ 33.48